American Society of Clinical Oncology

SHERPA: White

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Wolden
    Wolden
  4. La Quaglia
    La Quaglia
  5. Giralt
    Giralt
  6. Noy
    Noy
  7. Lesokhin
    Lesokhin
  8. Palomba
    Palomba
  9. Perales
    Perales
  10. Cheung
    Cheung

Groups

  1. Center for Hematologic Malignancies (902)
  2. Department of Medicine (754)
  3. Hematologic Malignancies, Division of (721)
  4. Lymphoma (289)
  5. Adult Leukemia (224)
  6. GSK Faculty (208)
  7. Survivorship Research (202)
  8. Pediatric Leukemia (174)
  9. Pediatrics, Department of (158)
  10. Tow Center for Developmental Oncology (TCDO) (134)
Search Within
  1. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (579)
  2. Journal Article (308)
  3. Editorial (6)
  4. Review (6)
  5. Correspondence (2)
  6. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (902)
  2. Department of Medicine (754)
  3. Hematologic Malignancies, Division of (721)
  4. Lymphoma (289)
  5. Adult Leukemia (224)
  6. GSK Faculty (208)

More Groups

People
  1. Andrew Zelenetz (85)
  2. Steven Horwitz (65)
  3. Suzanne Wolden (63)
  4. David Straus (46)
  5. Michael La Quaglia (43)
  6. Ariela Noy (42)

More People

Years
  1. 2025 (7)
  2. 2024 (49)
  3. 2023 (54)
  4. 2022 (58)
  5. 2021 (54)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (857)
  2. JCO Precision Oncology (19)
  3. Journal of Oncology Practice (12)
  4. American Society of Clinical Oncology Educational Book (11)
  5. JCO Clinical Cancer Informatics (3)

Results (902)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Management of transaminase elevations in patients receiving idelalisib
    Meeting Abstract

    Wierda, W. G.; Coutre, S.; Flinn, I.; Gopal, A. K.; O'Brien, S. M.; Salles, G. A.; Zelenetz, A. D.; Newcomb, T.; Waldapfel, C. C.; Ye, W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase lb dose escalation trial of isatuximab (SAR650984, anti-CD38 mAb) plus lenalidomide and dexamethasone (Len/Dex) in relapsed/refractory multiple myeloma (RRMM): Interim results from two new dose cohorts
    Meeting Abstract

    Vij, R.; Lendvai, N.; Martin, T. G.; Baz, R. C.; Campana, F.; Mazuir, F.; Charpentier, E.; Benson, D. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase III randomized, open-label study comparing the efficacy and safety of AG-221 vs conventional care regimens (CCR) in older patients with advanced acute myeloid leukemia (AML) with isocitrate dehydrogenase (IDH)-2 mutations in relapse or refractory to multiple prior treatments: The IDHENTIFY trial
    Meeting Abstract

    Tallman, M. S.; Knight, R. D.; Glasmacher, A. G.; Dohner, H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Romiplostim management of chemotherapy-induced thrombocytopenia
    Meeting Abstract

    Soff, G. A.; Parameswaran, R.; Mantha, S.; Miao, Y.; Mones, J. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies
    Meeting Abstract

    Soumerai, J. D.; Barrientos, J. C.; Hallek, M.; Kipps, T. J.; Jones, J. A.; Stilgenbauer, S.; Xing, G.; Yao, N. S.; Ysebaert, L.; Zelenetz, A. D.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose-escalation, multicenter study to evaluate the tolerability, safety, pharmacokinetics, and activity of ADCT-301 in patients with relapsed or refractory CD25-positive acute myeloid leukemia
    Meeting Abstract

    Tallman, M. S.; Feingold, J. M.; Spira, A. I.; Rizzieri, D.; Atallah, E. L.; Stock, W.; Jain, N.; Walter, R. B.; Chung, K. Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Pre-cancer cardiovascular risk factors and anthracycline-related cardiotoxicity among non-Hodgkin lymphoma survivors
    Meeting Abstract

    Salz, T.; Brown, P.; Zabor, E. C.; Dalton, S. O.; Raghunathan, N. J.; Matasar, M. J.; Steingart, R.; Vickers, A. J.; Oeffinger, K. C.; Johansen, C.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children's Oncology Group ARAR0332 protocol
    Meeting Abstract

    Rodriguez-Galindo, C.; Pappo, A. S.; Krailo, M. D.; Pashankar, F.; Caran, E. M. M.; Hicks, J.; McCarville, M. B.; Weldon, C. B.; Malkin, D.; Zambetti, G.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Richter, J. R.; Martin, T. G.; Vij, R.; Cole, C.; Atanackovic, D.; Zonder, J. A.; Kaufman, J. L.; Mikhael, J.; Bensinger, W.; Dimopoulos, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save